Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial

1. Ribera, J.-M.
2. Oriol, A.
3. Bethencourt, C.
4. Parody, R.
5. Hernández-Rivas, J.-M.
6. Moreno, M.-J.
7. Del Potro, E.
8. Tormo, M.
9. Rivas, C.
10. Besalduch, J.
11. Sanz, M.-Á.
12. Ortega, J.-J.